Current position

The Vanguard Group, Inc.’s Elevance Health Inc Formerly (ANTM) position

Reported position history, portfolio importance and verified filing changes from public SEC disclosures.

The Vanguard Group, Inc.Verified through Q4 2025
Relationship snapshot

At a glance

The full verified relationship, including prior ownership episodes and exits where supported.

First reportedQ4 2014Earliest verified positive filing snapshot
Latest statusCurrent positionBased on the latest supported relationship state
Peak shares23.02MHighest verified quarter-end share count
Quarters reported45Verified quarters with shares above zero
What happened?

The Vanguard Group, Inc. first reported Elevance Health Inc Formerly in Q4 2014. The reported position was increased and reduced across later filings. The Vanguard Group, Inc. currently reports 23.02M shares. The latest verified filing showed: Bought 0.09% more.

Verified SEC history

Position over time

See the same verified relationship through reported shares, portfolio weight or reported value.

Metric

Gaps indicate periods that cannot be safely connected or where a verified corporate action changes the raw share scale. Stock price, when available, is market context and not a transaction price.

Key filing events

What changed

Latest filing plus the most meaningful reported changes. Unchanged quarters are collapsed by default.

Q4 2025
Bought 0.09% more+20.87K shares · 23.02M shares reported after the change
Filing context

Quarter-end price $350.55 · Estimated holding basis $204.64

Q3 2025
Bought 0.6% more+141.75K shares · 23.00M shares reported after the change
Filing context

Quarter-end price $323.12 · Estimated holding basis $204.51

Q2 2025
Bought 3.2% more+704.79K shares · 22.86M shares reported after the change
Filing context

Quarter-end price $388.96 · Estimated holding basis $203.78

Q1 2025
Bought 3.1% more+666.53K shares · 22.15M shares reported after the change
Filing context

Quarter-end price $434.96 · Estimated holding basis $197.88

Q4 2024
Bought 0.6% more+138.38K shares · 21.49M shares reported after the change
Filing context

Quarter-end price $368.90 · Estimated holding basis $190.53

Q3 2024
Bought 0.7% more+140.27K shares · 21.35M shares reported after the change
Filing context

Quarter-end price $520.00 · Estimated holding basis $189.37

Portfolio importance

How important is Elevance Health Inc Formerly in The Vanguard Group, Inc.’s reported portfolio?

Relative importance is measured only within the verified primary non-option reported portfolio for each quarter.

Current portfolio weight0.1%Q4 2025
Current rank#143of 4329 reported positions
Peak portfolio weight0.3%Q4 2022
Best historical rank#58Q3 2022
SEC evidence & methodology

SEC filing evidence

Market context and filing-derived values are kept separate from actual transaction prices, which 13F filings do not disclose.

Latest filing quarter-end price$350.55Q4 2025

Derived from validated reported value and shares where supported.

Estimated holding basis$204.64Historical reference — not actual purchase price

Calculated from supported filing history.

Latest verified investor filingQ4 2025 · filed 2026-01-29
Open SEC filing ↗

Coverage is bounded to Vanguard’s top reported positions and material events rather than every security in each Form 13F. The filing reflects reportable U.S.-listed holdings, not Vanguard’s complete global assets, fund-by-fund ownership, exact trade dates or execution prices.